Share This Page
Drugs Containing Excipient (Inactive Ingredient) FD&C RED NO. 40 ALUMINUM LAKE
✉ Email this page to a colleague
Generic drugs containing FD&C RED NO. 40 ALUMINUM LAKE excipient
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| L. Perrigo Company | famotidine, calcium carbonate and magnesium hydroxide | 0113-0032 | FD&C RED NO. 40 ALUMINUM LAKE |
| Walgreen Company | famotidine, calcium carbonate and magnesium hydroxide | 0363-0511 | FD&C RED NO. 40 ALUMINUM LAKE |
| Walgreen Company | ibuprofen | 0363-1517 | FD&C RED NO. 40 ALUMINUM LAKE |
| >Company | >Ingredient | >NDC | >Excipient |
FD&C RED NO. 40 ALUMINUM LAKE: Market Dynamics and Financial Trajectory
FD&C Red No. 40 Aluminum Lake is a synthetic red colorant widely used in pharmaceuticals, particularly in solid dosage forms like tablets and capsules. Its stability, inertness, and color intensity make it a preferred choice for pharmaceutical manufacturers. The market for FD&C Red No. 40 Aluminum Lake is influenced by regulatory landscapes, demand from the pharmaceutical sector, and the availability of alternative colorants.
What is the Current Market Size and Projected Growth for FD&C Red No. 40 Aluminum Lake?
The global market for FD&C Red No. 40 Aluminum Lake is a segment within the broader pharmaceutical excipients market. Precise figures for this specific lake are not always segregated in high-level market reports, but its significant application in widely prescribed medications indicates a substantial market presence.
- Estimated Market Size: While specific, publicly available data for FD&C Red No. 40 Aluminum Lake alone is scarce, the global pharmaceutical excipients market was valued at approximately $8.9 billion in 2022 [1]. Colorants, including lakes, represent a portion of this market. Based on application rates in various formulations, the FD&C Red No. 40 Aluminum Lake segment likely represents a multi-million dollar market globally.
- Projected Growth: The pharmaceutical excipients market is projected to grow at a Compound Annual Growth Rate (CAGR) of 6.5% to 7.2% from 2023 to 2030 [1, 2]. This growth is driven by the increasing global demand for pharmaceuticals, particularly in emerging economies, and the development of new drug formulations. The demand for FD&C Red No. 40 Aluminum Lake is expected to mirror this overall trend, driven by its continued use in established and new pharmaceutical products. Factors influencing growth include:
- Increased Drug Production: A rise in the manufacturing of tablets and capsules globally directly translates to higher demand for colorants.
- Regulatory Acceptance: Its established regulatory status in major markets supports its continued use.
- Cost-Effectiveness: Compared to some natural colorants, synthetic lakes often offer a more stable and cost-effective coloring solution for large-scale pharmaceutical production.
What are the Key Applications and End-User Industries for FD&C Red No. 40 ALUMINUM LAKE?
The primary application of FD&C Red No. 40 Aluminum Lake is as a colorant in pharmaceutical formulations. Its distinct red hue is crucial for product identification, differentiation, and aesthetic appeal, which can influence patient compliance.
- Pharmaceutical Formulations:
- Tablets: Used for coating or coloring the tablet matrix to achieve specific shades of red. This is critical for distinguishing different strengths or types of medication.
- Capsules: Incorporated into the gelatin or HPMC shells of capsules.
- Oral Suspensions and Solutions: Though less common due to potential solubility issues in liquid formulations, it can be used when appropriately dispersed.
- Topical Preparations: In some creams and ointments where a red color is desired for identification or aesthetic purposes.
- End-User Industries:
- Pharmaceutical Manufacturing Companies: These are the direct consumers, purchasing the lake for incorporation into their finished drug products.
- Contract Manufacturing Organizations (CMOs): CMOs that specialize in drug formulation and manufacturing represent a significant user base.
- Nutraceutical and Dietary Supplement Manufacturers: While the primary focus is pharmaceuticals, this colorant can also be used in some vitamin and supplement formulations, though regulations might differ.
What are the Dominant Manufacturing Processes and Key Suppliers?
The production of FD&C Red No. 40 Aluminum Lake involves a chemical precipitation process. The key raw materials are FD&C Red No. 40 and aluminum salts.
- Manufacturing Process:
- Dye Preparation: FD&C Red No. 40 (also known as Allura Red AC) is prepared.
- Precipitation: A soluble aluminum salt, typically aluminum chloride or aluminum sulfate, is added to an aqueous solution or dispersion of the dye under controlled pH and temperature conditions.
- Lake Formation: The aluminum ions react with the dye molecule, forming an insoluble complex known as an aluminum lake. The insolubility is crucial for its application in solid dosage forms.
- Filtration and Drying: The precipitated lake is filtered, washed to remove impurities, and then dried to a fine powder.
- Milling and Standardization: The dried product is milled to achieve the desired particle size distribution, and standardized to ensure consistent color strength and quality.
- Key Suppliers: The market is characterized by several global chemical manufacturers specializing in food and pharmaceutical colorants. Major players include:
- BASF SE: A prominent global supplier of a wide range of pharmaceutical excipients, including colorants.
- Sensient Technologies Corporation: A leader in colorants for food, pharmaceutical, and cosmetic applications.
- D.D. Williamson & Co., Inc.: While known for natural colors, they also offer synthetic options or can be a source through partnerships.
- ECKART GmbH: Specializes in effect pigments and metallic colors, but may also offer standard colorants.
- Various Chinese Manufacturers: China is a significant producer of many chemical ingredients, including dyes and lakes, for the global market. Companies like Hebei Chenyang Industry & Trade Co., Ltd. and Shandong Dayang Chemical Co., Ltd. are active in this space.
What is the Regulatory Landscape Governing FD&C Red No. 40 ALUMINUM LAKE in Pharmaceuticals?
The use of FD&C Red No. 40 Aluminum Lake in pharmaceuticals is strictly regulated by health authorities in different countries to ensure patient safety.
- United States:
- Governed by the Food and Drug Administration (FDA).
- FD&C Red No. 40 is listed as a permitted color additive in pharmaceuticals under 21 CFR Part 74.3405 [3].
- Aluminum lakes of such dyes are permitted for use in pharmaceuticals, provided they meet the specifications outlined in the relevant FDA regulations.
- Specific purity criteria and limits on heavy metals and other impurities are mandated.
- European Union:
- Regulated by the European Medicines Agency (EMA) and national competent authorities.
- Colorants used in medicinal products are covered by Regulation (EC) No 1333/2008 on food additives and Commission Regulation (EU) No 231/2012 laying down specifications for food additives [4].
- FD&C Red No. 40 (E 129) is permitted as a food additive and its use in pharmaceuticals is governed by national regulations and the general principles of medicinal product regulation. Specific requirements for pharmaceutical use would align with standards for excipients.
- Other Regions:
- Japan: Regulated by the Ministry of Health, Labour and Welfare (MHLW).
- Canada: Health Canada oversees the use of colorants in pharmaceuticals.
- Compliance with the pharmacopoeial standards (e.g., United States Pharmacopeia - USP, European Pharmacopoeia - Ph. Eur.) is generally required, which sets stringent quality and purity standards.
What are the Primary Market Drivers and Restraints?
The market dynamics for FD&C Red No. 40 Aluminum Lake are shaped by several factors.
- Market Drivers:
- Growing Pharmaceutical Market: The continuous expansion of the global pharmaceutical industry, driven by an aging population, increasing prevalence of chronic diseases, and rising healthcare expenditure, fuels demand for all pharmaceutical excipients, including colorants.
- Preference for Solid Dosage Forms: Tablets and capsules remain the most common and cost-effective drug delivery systems, directly increasing the need for colorants like FD&C Red No. 40 Aluminum Lake.
- Established Safety Profile and Regulatory Acceptance: For decades, FD&C Red No. 40 Aluminum Lake has been used and evaluated by regulatory bodies, providing a level of confidence for manufacturers. Its inclusion in major pharmacopoeias reinforces its acceptability.
- Cost-Effectiveness and Stability: Compared to natural colorants, synthetic lakes like FD&C Red No. 40 Aluminum Lake often offer superior stability under various processing conditions (light, pH, temperature) and can be more economical for large-scale production.
- Product Differentiation and Brand Identity: Consistent and distinct coloring is essential for brand recognition and preventing medication errors. Red is a frequently used color for this purpose.
- Market Restraints:
- Concerns over Synthetic Dyes: Despite regulatory approval, there are ongoing public and some scientific discussions regarding the potential health impacts of certain synthetic food and drug colorants, which can lead to consumer pressure for "clean label" products. While FD&C Red No. 40 has undergone extensive review, any perceived association with adverse effects can be a restraint.
- Rise of Natural Colorants: The growing consumer preference for natural ingredients has led to increased research and development in natural colorants for pharmaceutical applications. While natural alternatives can be less stable and more expensive, their adoption can reduce demand for synthetic lakes.
- Regulatory Scrutiny and Potential Revisions: Regulatory bodies continuously review scientific data. Any new findings suggesting safety concerns could lead to revised regulations, restrictions, or even bans, creating market uncertainty.
- Availability of Alternatives: Beyond natural colorants, other synthetic dyes and pigments offer a range of colors, and manufacturers may choose alternatives based on specific formulation needs, cost, or perceived consumer preference.
What is the Competitive Landscape and Potential for Innovation?
The competitive landscape is moderately concentrated, with a few large global players and numerous smaller regional manufacturers.
- Competitive Dynamics:
- Price Sensitivity: Pharmaceutical manufacturers, particularly generics producers, are often sensitive to the cost of excipients. Price competition among suppliers is significant.
- Quality and Consistency: Beyond price, suppliers must demonstrate consistent product quality, purity, and reliability of supply to secure long-term contracts. Adherence to Good Manufacturing Practices (GMP) is critical.
- Regulatory Compliance: The ability to provide comprehensive documentation supporting regulatory compliance in various target markets is a key competitive advantage.
- Technical Support: Offering formulation support and troubleshooting to pharmaceutical clients can differentiate suppliers.
- Potential for Innovation:
- Enhanced Purity and Reduced Impurities: Research could focus on optimizing manufacturing processes to further minimize residual solvents or trace impurities, meeting ever-stricter regulatory requirements.
- Particle Size Engineering: Developing specific particle size distributions to improve dispersibility, flowability, and uniformity in various pharmaceutical formulations.
- Synergistic Blends: While FD&C Red No. 40 Aluminum Lake is a distinct colorant, innovation might involve developing optimized blends with other colorants to achieve unique shades or improved performance characteristics.
- Sustainability in Production: Exploring greener manufacturing processes that reduce waste or energy consumption.
What are the Financial Projections and Investment Considerations?
The financial trajectory of FD&C Red No. 40 Aluminum Lake is tied to the overall growth of the pharmaceutical sector and the specific trends within the colorant market.
- Financial Projections:
- Steady Revenue Growth: Demand is expected to grow in line with the pharmaceutical excipients market, indicating a stable, albeit moderate, revenue stream for established suppliers.
- Profitability: Profit margins can be influenced by raw material costs (e.g., dye intermediates, aluminum salts), energy prices, and the level of competition. Efficient manufacturing and supply chain management are key to maintaining profitability.
- Market Share Stability: While new entrants are possible, the established players with strong regulatory track records and supply chain reliability are likely to maintain their market share.
- Investment Considerations:
- Mature Market: FD&C Red No. 40 Aluminum Lake is a well-established product. Investments are more likely to be in optimizing existing production capacity, quality control, and supply chain efficiency rather than in groundbreaking new product development for this specific lake.
- Risk Mitigation: Investors should consider the regulatory risk associated with synthetic dyes and the competitive pressure from natural alternatives. Diversification within the excipients portfolio or focusing on suppliers with strong intellectual property or proprietary production methods would be prudent.
- Geographic Expansion: Opportunities may exist for suppliers to expand their reach into emerging pharmaceutical markets where demand for cost-effective and reliable excipients is growing.
- Acquisition Targets: Smaller manufacturers with niche expertise or strong regional market penetration could be acquisition targets for larger chemical conglomerates looking to expand their pharmaceutical excipient offerings.
Key Takeaways
- FD&C Red No. 40 Aluminum Lake is a key colorant in solid pharmaceutical dosage forms, with its market growth mirroring the broader pharmaceutical excipients sector.
- Regulatory acceptance in major markets like the US and EU, coupled with its cost-effectiveness and stability, underpins continued demand.
- The market is driven by the expanding global pharmaceutical industry and the enduring preference for tablet and capsule formulations.
- Restraints include public perception regarding synthetic dyes and the increasing adoption of natural colorants.
- Competition focuses on price, quality, and regulatory compliance, with limited scope for radical innovation in the product itself, but opportunities in process optimization and supply chain management.
- Investment opportunities lie in established players with efficient operations and strong regulatory support, with a need to monitor evolving regulatory landscapes and consumer trends.
Frequently Asked Questions
-
What is the difference between FD&C Red No. 40 and FD&C Red No. 40 Aluminum Lake? FD&C Red No. 40 is a water-soluble dye, while FD&C Red No. 40 Aluminum Lake is an insoluble pigment formed by precipitating the dye with an aluminum salt. The insolubility of the lake makes it suitable for solid dosage forms like tablets and capsules where water solubility is not desired.
-
Are there any known health risks associated with FD&C Red No. 40 Aluminum Lake in pharmaceuticals? FD&C Red No. 40 Aluminum Lake has undergone extensive safety evaluations by regulatory agencies such as the FDA and EMA. It is permitted for use in pharmaceuticals when manufactured to meet strict purity standards. As with many synthetic colorants, some consumers express preferences for natural alternatives, but approved synthetic dyes are considered safe for their intended use.
-
How does the stability of FD&C Red No. 40 Aluminum Lake compare to natural red colorants in pharmaceuticals? FD&C Red No. 40 Aluminum Lake generally offers superior stability compared to many natural red colorants, such as anthocyanins or carmine. It is more resistant to degradation from light, heat, and pH variations encountered during pharmaceutical manufacturing and storage, ensuring consistent product appearance over its shelf life.
-
What are the primary reasons for choosing FD&C Red No. 40 Aluminum Lake over other red colorants in pharmaceutical formulations? Key reasons include its high tinctorial strength (meaning a little goes a long way), excellent stability, predictable color hue, established regulatory approval, and cost-effectiveness for large-scale production. Its insolubility is also a critical factor for solid dosage forms.
-
Can FD&C Red No. 40 Aluminum Lake be used in all types of pharmaceutical formulations? It is primarily used in solid dosage forms like tablets and capsules. While it can be dispersed for use in some liquid or semi-solid formulations, its insolubility may present challenges for achieving a homogenous and stable dispersion compared to water-soluble dyes. Its suitability depends on the specific formulation requirements and excipient compatibility.
Citations
[1] Grand View Research. (2023). Pharmaceutical Excipients Market Size, Share & Trends Analysis Report By Type (Functional, Non-Functional), By Product (Binders, Fillers, Coatings, Disintegrants, Lubricants, Colorants, Others), By End-use (Pharma, Nutraceuticals), By Region, And Segment Forecasts, 2023 - 2030. Retrieved from https://www.grandviewresearch.com/industry-analysis/pharmaceutical-excipients-market
[2] MarketsandMarkets. (2023). Pharmaceutical Excipients Market - Global Forecast to 2028. Retrieved from https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-excipients-market-687.html
[3] U.S. Food and Drug Administration. (n.d.). 21 CFR Part 74 - Color additives listed for use in drugs. Retrieved from https://www.ecfr.gov/current/title-21/chapter-I/subchapter-A/part-74
[4] European Parliament and Council. (2008). Regulation (EC) No 1333/2008 of the European Parliament and of the Council of 16 December 2008 on food additives. Official Journal of the European Union, L 354/16.
More… ↓
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
Visit the Subscription Options page for details on plans and pricing.
ISSN: 2162-2639

Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Access the Complete Database
Deeper Knowledge, Faster
- Analyze global market entry opportunities
- Identify first generic entrants
- Drug patents in 130+ countries